Copyright Reports & Markets. All rights reserved.

Global Metabotropic Glutamate Receptor 5 Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Metabotropic Glutamate Receptor 5 Market Overview

      • 1.1 Product Overview and Scope of Metabotropic Glutamate Receptor 5
      • 1.2 Metabotropic Glutamate Receptor 5 Segment by Type
        • 1.2.1 Global Metabotropic Glutamate Receptor 5 Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Alloswitch-1
        • 1.2.3 BMS-952048
        • 1.2.4 BMS-955829
        • 1.2.5 Dipraglurant ER
        • 1.2.6 Others
      • 1.3 Metabotropic Glutamate Receptor 5 Segment by Application
        • 1.3.1 Metabotropic Glutamate Receptor 5 Consumption Comparison by Application (2014-2025)
        • 1.3.2 Major Depressive Disorder
        • 1.3.3 Alcohol Assiction
        • 1.3.4 Alzheimer's Disease
        • 1.3.5 Others
      • 1.3 Global Metabotropic Glutamate Receptor 5 Market by Region
        • 1.3.1 Global Metabotropic Glutamate Receptor 5 Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Metabotropic Glutamate Receptor 5 Market Size
        • 1.4.1 Global Metabotropic Glutamate Receptor 5 Revenue (2014-2025)
        • 1.4.2 Global Metabotropic Glutamate Receptor 5 Production (2014-2025)

      2 Global Metabotropic Glutamate Receptor 5 Market Competition by Manufacturers

      • 2.1 Global Metabotropic Glutamate Receptor 5 Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Metabotropic Glutamate Receptor 5 Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Metabotropic Glutamate Receptor 5 Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Metabotropic Glutamate Receptor 5 Production Sites, Area Served, Product Types
      • 2.5 Metabotropic Glutamate Receptor 5 Market Competitive Situation and Trends
        • 2.5.1 Metabotropic Glutamate Receptor 5 Market Concentration Rate
        • 2.5.2 Metabotropic Glutamate Receptor 5 Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Metabotropic Glutamate Receptor 5 Production Market Share by Regions

      • 3.1 Global Metabotropic Glutamate Receptor 5 Production Market Share by Regions
      • 3.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Metabotropic Glutamate Receptor 5 Production
        • 3.4.1 North America Metabotropic Glutamate Receptor 5 Production Growth Rate (2014-2019)
        • 3.4.2 North America Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Metabotropic Glutamate Receptor 5 Production
        • 3.5.1 Europe Metabotropic Glutamate Receptor 5 Production Growth Rate (2014-2019)
        • 3.5.2 Europe Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Metabotropic Glutamate Receptor 5 Production (2014-2019)
        • 3.6.1 China Metabotropic Glutamate Receptor 5 Production Growth Rate (2014-2019)
        • 3.6.2 China Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Metabotropic Glutamate Receptor 5 Production (2014-2019)
        • 3.7.1 Japan Metabotropic Glutamate Receptor 5 Production Growth Rate (2014-2019)
        • 3.7.2 Japan Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Metabotropic Glutamate Receptor 5 Consumption by Regions

      • 4.1 Global Metabotropic Glutamate Receptor 5 Consumption by Regions
      • 4.2 North America Metabotropic Glutamate Receptor 5 Consumption (2014-2019)
      • 4.3 Europe Metabotropic Glutamate Receptor 5 Consumption (2014-2019)
      • 4.4 China Metabotropic Glutamate Receptor 5 Consumption (2014-2019)
      • 4.5 Japan Metabotropic Glutamate Receptor 5 Consumption (2014-2019)

      5 Global Metabotropic Glutamate Receptor 5 Production, Revenue, Price Trend by Type

      • 5.1 Global Metabotropic Glutamate Receptor 5 Production Market Share by Type (2014-2019)
      • 5.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2014-2019)
      • 5.3 Global Metabotropic Glutamate Receptor 5 Price by Type (2014-2019)
      • 5.4 Global Metabotropic Glutamate Receptor 5 Production Growth by Type (2014-2019)

      6 Global Metabotropic Glutamate Receptor 5 Market Analysis by Applications

      • 6.1 Global Metabotropic Glutamate Receptor 5 Consumption Market Share by Application (2014-2019)
      • 6.2 Global Metabotropic Glutamate Receptor 5 Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Metabotropic Glutamate Receptor 5 Business

      • 7.1 Addex Therapeutics Ltd
        • 7.1.1 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 7.1.2 Metabotropic Glutamate Receptor 5 Product Introduction, Application and Specification
        • 7.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Aevi Genomic Medicine Inc
        • 7.2.1 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 7.2.2 Metabotropic Glutamate Receptor 5 Product Introduction, Application and Specification
        • 7.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Bristol-Myers Squibb Company
        • 7.3.1 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 7.3.2 Metabotropic Glutamate Receptor 5 Product Introduction, Application and Specification
        • 7.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Eisai Co Ltd
        • 7.4.1 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 7.4.2 Metabotropic Glutamate Receptor 5 Product Introduction, Application and Specification
        • 7.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Eli Lilly and Company
        • 7.5.1 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 7.5.2 Metabotropic Glutamate Receptor 5 Product Introduction, Application and Specification
        • 7.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Heptares Therapeutics Ltd
        • 7.6.1 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 7.6.2 Metabotropic Glutamate Receptor 5 Product Introduction, Application and Specification
        • 7.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Johnson & Johnson
        • 7.7.1 Johnson & Johnson Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 7.7.2 Metabotropic Glutamate Receptor 5 Product Introduction, Application and Specification
        • 7.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Merz Pharma GmbH & Co KgaA
        • 7.8.1 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 7.8.2 Metabotropic Glutamate Receptor 5 Product Introduction, Application and Specification
        • 7.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Novartis AG
        • 7.9.1 Novartis AG Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 7.9.2 Metabotropic Glutamate Receptor 5 Product Introduction, Application and Specification
        • 7.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Richter Gedeon Nyrt
        • 7.10.1 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 7.10.2 Metabotropic Glutamate Receptor 5 Product Introduction, Application and Specification
        • 7.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Sumitomo Dainippon Pharma Co Ltd
      • 7.12 Toray Industries Inc

      8 Metabotropic Glutamate Receptor 5 Manufacturing Cost Analysis

      • 8.1 Metabotropic Glutamate Receptor 5 Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor 5
      • 8.4 Metabotropic Glutamate Receptor 5 Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Metabotropic Glutamate Receptor 5 Distributors List
      • 9.3 Metabotropic Glutamate Receptor 5 Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Metabotropic Glutamate Receptor 5 Market Forecast

      • 11.1 Global Metabotropic Glutamate Receptor 5 Production, Revenue Forecast
        • 11.1.1 Global Metabotropic Glutamate Receptor 5 Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Metabotropic Glutamate Receptor 5 Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Metabotropic Glutamate Receptor 5 Price and Trend Forecast (2019-2025)
      • 11.2 Global Metabotropic Glutamate Receptor 5 Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Metabotropic Glutamate Receptor 5 Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Metabotropic Glutamate Receptor 5 Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Metabotropic Glutamate Receptor 5 Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Metabotropic Glutamate Receptor 5 Production, Revenue Forecast (2019-2025)
      • 11.3 Global Metabotropic Glutamate Receptor 5 Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Metabotropic Glutamate Receptor 5 Consumption Forecast (2019-2025)
        • 11.3.2 Europe Metabotropic Glutamate Receptor 5 Consumption Forecast (2019-2025)
        • 11.3.3 China Metabotropic Glutamate Receptor 5 Consumption Forecast (2019-2025)
        • 11.3.4 Japan Metabotropic Glutamate Receptor 5 Consumption Forecast (2019-2025)
      • 11.4 Global Metabotropic Glutamate Receptor 5 Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Metabotropic Glutamate Receptor 5 Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Metabotropic Glutamate Receptor 5 market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Metabotropic Glutamate Receptor 5 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Metabotropic Glutamate Receptor 5 market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Addex Therapeutics Ltd
        Aevi Genomic Medicine Inc
        Bristol-Myers Squibb Company
        Eisai Co Ltd
        Eli Lilly and Company
        Heptares Therapeutics Ltd
        Johnson & Johnson
        Merz Pharma GmbH & Co KgaA
        Novartis AG
        Richter Gedeon Nyrt
        Sumitomo Dainippon Pharma Co Ltd
        Toray Industries Inc

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Alloswitch-1
        BMS-952048
        BMS-955829
        Dipraglurant ER
        Others

        Segment by Application
        Major Depressive Disorder
        Alcohol Assiction
        Alzheimer's Disease
        Others

        Buy now